NAD+ Benefits: What It Does and What Studies Show

Explore NAD+'s role in cellular energy metabolism, measured findings from oral studies, and practical ways to compare formulas.
Three abstract evidence cards distinguish cellular biology, a biomarker and a human outcome.
Three abstract evidence cards distinguish cellular biology, a biomarker and a human outcome.

NAD+ helps cells turn food into usable energy and supports enzyme-driven cellular processes. Human oral-supplement research is now testing how specific formulations influence NAD+ levels. The molecule helps carry electrons in energy metabolism and serves enzymes involved in cellular processes.

Those facts make NAD+ worth studying. They do not show that a capsule gives people more energy, sharper thinking, better exercise performance, or a longer life.

“NAD+ benefits” is a broad search phrase, so this article draws the lines plainly. First: what endogenous NAD+ does in the body. Second: what has happened when researchers gave people NAD+ itself by mouth. Third: why results from NAD+ precursors such as NMN and NR cannot be treated as trials of a direct NAD+ product.

NAD+ is a dinucleotide coenzyme; the question here is whether adding it by mouth changes a meaningful human outcome.

NAD supplement benefits: What have human trials measured?

Direct human research on oral NAD+ is early and formulation-specific. A 2026 randomized trial of a modified powder found a short-term increase in whole-blood intracellular total NAD (NAD+ plus NADH); it did not establish a clinical benefit or test an ordinary capsule.

Several trials of NMN and NR, which are precursors rather than NAD+ itself, show changes in blood NAD+ and some mixed, narrow functional findings. These results concern the studied ingredients and endpoints, not a demonstrated effect on aging, disease prevention or lifespan.

NAD benefits: How does it support cellular energy?

Here the wording matters. NAD+ inside the body helps reactions that extract energy from food. In those reactions, NAD+ accepts electrons and becomes NADH; NADH later gives them up and cycles back. The process is fundamental to life. Calling NAD+ a coenzyme for energy metabolism is accurate biology.

But a reader usually hears “benefits” as “will I feel more energetic?” That is an outcome question. A fatigued person may have poor sleep, iron deficiency, a medication effect, a thyroid problem, or one of many other causes.

A supplement's role in a cellular pathway does not establish that swallowing it changes fatigue. To prove that, a trial would need an appropriate group, a defined formula and dose, and validated measures of how people actually function or feel.

The five-day oral trial did not supply that proof. It measured a blood-cell biomarker, not a dependable improvement in everyday energy. The finding helps researchers understand oral delivery in the specific form studied; everyday energy is a separate outcome to measure.

Can oral NAD+ change measured NAD levels?

In the direct LNAD+ study, 60 healthy adults aged 45–75 were randomized; the primary analysis included 50. The active arm used a proprietary powder that was 50% NAD+, with four 500 mg powder doses daily for five days and an extra 500 mg powder dose at night on days 2 and 3.

The administration was swish-and-swallow. At day 6, the whole-blood intracellular total NAD measurement (NAD+ plus NADH) was 53% higher than placebo. Plasma total NAD did not change significantly; other tissues were not measured. That makes the exact measured compartment important: a “NAD+ levels” headline without naming the sample can obscure the result.

The product was modified and proprietary. Its repeated powder-dosing protocol and swish-and-swallow delivery design differed from the labeled Infinite Labs capsule routine. The trial says nothing definitive about the biomarker response to our capsule. Nor does a higher blood-cell marker prove an improvement in muscle, brain, or other tissues. That second leap requires its own measurements and outcomes.

Research on precursors provides more biomarker data. In an 80-person NMN study, 300–900 mg daily for 60 days raised serum total NAD (NAD+ plus NADH) in the active groups. A NR crossover study also found higher blood NAD+ after six weeks.

Useful science, but neither trial tested swallowing NAD+ itself. Keep the precursor results distinct from the direct oral NAD+ findings when comparing the studies.

What do NAD-related studies show about exercise and metabolism?

Some NMN studies have reported signals on walking or muscle measures. The 80-person NMN trial included a secondary six-minute walk test that favored NMN. Another trial in 25 postmenopausal women with prediabetes found improved muscle insulin sensitivity after 10 weeks of 250 mg NMN daily.

That is a specific physiologic finding in a selected population. It does not prove that direct NAD+ supplements improve workouts or manage glucose in healthy shoppers.

The broader human picture is uneven: the selected-population insulin-sensitivity finding, the NMN blood-marker and walking findings, and the direct NAD+ blood-marker result ask different questions. None establishes a reliable, broad benefit from an oral NAD+ capsule. The distinction between a positive endpoint in one small trial and a general health benefit is exactly where careful interpretation earns its keep.

What do we know about NAD+ and healthy aging?

No human study establishes that taking oral NAD+ makes people live longer or reverses aging. Experiments in animals and cells can generate hypotheses; they cannot substitute for human outcome trials. “Longevity” is also not one test. It would demand sustained evidence on health, function, disease, and survival over far longer than five days.

The premise that NAD+ universally falls with age in humans is more complicated than many charts suggest. The intervention studies cited here do not measure a lifetime trajectory across tissues. Tissue and measurement method matter.

Even if a decline is observed in one tissue, a supplement still has to show it reaches the relevant system and improves a meaningful outcome. Age alone does not establish an individual deficiency.

“Biological age” scores are sometimes used in small studies, but a lower score is not the same as proof of more healthy years. It is reasonable to follow this research with curiosity. It is not reasonable to put “age reversal” on a product promise.

What about brain health and immunity?

NAD+ participates in many cellular processes, including pathways researchers study in the brain and immune system. That breadth can make almost any proposed benefit sound plausible. Plausibility is a reason to run a trial, not a reason to skip one.

The direct oral powder study did not establish better memory, attention, mood, immune defense, or recovery from illness. Trials of precursors in selected populations cannot be generalized to a broad oral NAD+ capsule claim.

For a person with symptoms—persistent fatigue, memory changes, exercise intolerance—medical evaluation matters more than assuming an NAD+ deficit. A clinician can help you understand those symptoms and make supplement choices that fit your situation.

How can you interpret NAD+ research?

Three levels of evidence often blended into one sentence.
Claim level Example What it establishes
Biology NAD+ participates in energy metabolism The molecule has a cellular role
Biomarker A specific oral powder changed whole-blood intracellular total NAD (NAD+ plus NADH) A short-term measured response to that formulation
Clinical outcome People feel or function better Requires direct, well-designed human evidence; not established for our capsule

Ask five questions when reading a study: Which molecule was given? Which formulation and amount? To whom? For how long? What was the primary endpoint? A result from IV NAD+, NMN, or NR may help frame a hypothesis, but it does not answer a direct oral NAD+ capsule question. That distinction protects a shopper from assigning another ingredient's result to this one.

How does our NAD+ capsule fit your routine?

The verified Infinite Labs NAD+ label lists 500 mg NAD+ and 2.5 mg BioPerine® black pepper extract per capsule, with one capsule daily with food. A bottle has 30 servings.

Our once-daily capsule provides a clearly stated NAD+ serving that you can compare with other products and fit into a with-food routine.

If you choose to try an NAD+ product, treat it as a personal supplement decision, not a proven therapy. Follow the label. Discuss use with a clinician if you take medicines or have a condition. No published dose-finding trial has established an optimal oral amount for a general wellness outcome.

Frequently asked questions about NAD+ benefits

What is the difference between NAD benefits and NAD supplement benefits?

NAD+ already inside your cells helps energy metabolism and other enzyme-driven processes. A supplement is an outside source of the molecule. Human trials need to measure what happens with the particular oral formulation, dose and population.

Does a higher NAD blood marker prove that you will feel better?

No. A biomarker tells researchers that a measured biological response occurred. Everyday energy, exercise performance and other outcomes require their own measurements. The direct powder trial and precursor trials above report different types of findings.

How can you compare an NAD+ capsule with a trial?

Compare the molecule, formulation, serving, route, study duration and measured endpoint. The current Infinite Labs capsule states its NAD+ and BioPerine® amounts and a once-daily with-food routine; those label facts help you compare products without assuming that every studied preparation is identical.

Bottom line

NAD+ is indispensable in the body. Direct oral NAD+ has an interesting short-term biomarker trial, but no demonstrated broad human health benefit for the Infinite Labs capsule or ordinary NAD+ capsules generally. Precursor trials add information while testing different molecules.

Use the research to make a more informed choice: compare the exact molecule, formulation and serving, and distinguish measured NAD-marker changes from outcomes such as daily energy or exercise performance.

Sources

About the author

Arjun Sareen is CEO of Infinite Labs and Infinite Labs Digital and a contributor to the Infinite Labs Journal. This brand-owned guide provides educational information, not individual medical advice.

Keep it useful

Join the conversation